These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 87838)

  • 1. Tuberculosis chemotherapy--how long.
    Lancet; 1979 Jun; 1(8131):1383-4. PubMed ID: 87838
    [No Abstract]   [Full Text] [Related]  

  • 2. [Outlook for using a short course of chemotherapy in tuberculosis].
    Anastasatu C; Corlan E
    Probl Tuberk; 1987; (10):31-4. PubMed ID: 3122200
    [No Abstract]   [Full Text] [Related]  

  • 3. Sputum-smear-negative pulmonary tuberculosis: controlled trial of 3-month and 2-month regimens of chemotherapy.
    Lancet; 1979 Jun; 1(8131):1361-3. PubMed ID: 87829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of different chemotherapy regimens with pulmonary tuberculosis patients based on the data from a comprehensive bacteriological study].
    Muratov VV; Pashkov IuN; Chukanov VI
    Probl Tuberk; 1983 May; (5):34-8. PubMed ID: 6408636
    [No Abstract]   [Full Text] [Related]  

  • 5. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A; Rieder HL
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intermittent chemotherapy of chronic forms of pulmonary tuberculosis].
    Ershov AI; Tikhonov VA; Zheltukhina NI; Chesmochakova IV
    Probl Tuberk; 1976 Feb; (21):31-4. PubMed ID: 817283
    [No Abstract]   [Full Text] [Related]  

  • 7. [Methods in the modern chemotherapy of tuberculosis (a lecture)].
    Khomenko AG
    Probl Tuberk; 1988; (8):53-7. PubMed ID: 3143997
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
    Muratov VV; Pashkov IuN; Pospelov VV
    Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of early results of treatment of pulmonary tuberculosis in Mycobacterium-positive patients. Comparison of the results of 3- and 4-drug treatment].
    Martyniak K; Wyczółkowski M; Bochiński T
    Pneumonol Pol; 1985 Apr; 53(4):195-201. PubMed ID: 3931056
    [No Abstract]   [Full Text] [Related]  

  • 10. [Control of tuberculosis in Nepal. A project. Logistics, goals].
    Neher A; Breyer O; Blaha H; Shresta HB
    Pneumologie; 1990 Feb; 44 Suppl 1():477-8. PubMed ID: 2114633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of the inhalation of tuberculostatic aerosols on the dynamics of bacterial excretion in pulmonary tuberculosis patients].
    Protsiuk RG
    Probl Tuberk; 1983 May; (5):38-42. PubMed ID: 6408637
    [No Abstract]   [Full Text] [Related]  

  • 12. [New cases of pulmonary tuberculosis treatment within DOTS strategy].
    Zhangireev AA; Ismailov ShSh; Berikova EM
    Probl Tuberk; 2000; (3):23-5. PubMed ID: 10900979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study on the implementation of primary chemotherapy to pulmonary tuberculosis with positive bacillus].
    Tian XZ; Wang LX
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Aug; 16(4):220-2. PubMed ID: 7585902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-course daily chemotherapy for tuberculosis.
    Riehl ED; Bereznicki G
    Pa Med; 1979 Mar; 82(3):20-3. PubMed ID: 418988
    [No Abstract]   [Full Text] [Related]  

  • 15. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of adequate drug combinations in the treatment of cavernous tuberculosis].
    Seri I
    Prax Pneumol; 1971 Apr; 25(4):211-9. PubMed ID: 4995326
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical efficiency of combined chemotherapy of patients with progressive forms of pulmonary tuberculosis].
    Cheren'ko SO
    Lik Sprava; 2001; (1):76-80. PubMed ID: 15311700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Should chemotherapy for pulmonary tuberculosis be started after the completion of pretreatment sputum examination?].
    Ito K; Aono A; Yoshiyama T; Wada M; Ogata H
    Kekkaku; 2005 Dec; 80(12):735-41. PubMed ID: 16447786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Capreomycin in the combination treatment of chronic pulmonary tuberculosis].
    Sighart H; Opl G
    Prax Pneumol; 1970 Jan; 24(1):15-20. PubMed ID: 4984503
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.